JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder

被引:24
作者
Pardanani, A. [1 ]
Lasho, T. L. [1 ]
Schwager, S. [1 ]
Finke, C. [1 ]
Hussein, K. [1 ]
Pruthi, R. K. [1 ]
Tefferi, A. [1 ]
机构
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA
关键词
D O I
10.1038/sj.leu.2404710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1828 / 1829
页数:3
相关论文
共 7 条
[1]   Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis [J].
Boissinot, Marjorie ;
Lippert, Eric ;
Girodon, Francois ;
Dobo, Irene ;
Fouassier, Marc ;
Masliah, Claude ;
Praloran, Vincent ;
Hermouet, Sylvie .
BLOOD, 2006, 108 (09) :3223-3224
[2]   Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study [J].
Campbell, PJ ;
Scott, LM ;
Buck, G ;
Wheatley, K ;
East, CL ;
Marsden, JT ;
Duffy, A ;
Boyd, EM ;
Bench, AJ ;
Scott, MA ;
Vassiliou, GS ;
Milligan, DW ;
Smith, SR ;
Erber, WN ;
Bareford, D ;
Wilkins, BS ;
Reilly, JT ;
Harrison, CN ;
Green, AR .
LANCET, 2005, 366 (9501) :1945-1953
[3]   X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and NIMM patients with clonal hematopoiesis [J].
Levine, Ross L. ;
Belisle, Claude ;
Wadleigh, Martha ;
Zahrieh, David ;
Lee, Stephanie ;
Chagnon, Pierre ;
Gilliland, D. Gary ;
Busque, Lambert .
BLOOD, 2006, 107 (10) :4139-4141
[4]   Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome [J].
Patel, Raj K. ;
Lea, Nicholas C. ;
Heneghan, Michael A. ;
Westwood, Nigel B. ;
Milojkovic, Dragana ;
Thanigaikumar, Murugaiyan ;
Yallop, Deborah ;
Arya, Roopen ;
Pagliuca, Antonio ;
Gaken, Joop ;
Wendon, Julia ;
Heaton, Nigel D. ;
Mufti, Ghulam J. .
GASTROENTEROLOGY, 2006, 130 (07) :2031-2038
[5]   Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis [J].
Primignani, Massimo ;
Barosi, Giovanni ;
Bergamaschi, Gaetano ;
Gianelli, Umberto ;
Fabris, Federica ;
Reati, Raffaella ;
Dell'Era, Alessandra ;
Bucciarelli, Paolo ;
Mannucci, Pier Mannuccio .
HEPATOLOGY, 2006, 44 (06) :1528-1534
[6]   The V617F mutation of JAK2 is very uncommon in patients with thrombosis [J].
Remacha, Angel F. ;
Estivill, Camino ;
Pilar Sarda, M. ;
Mateo, Jose ;
Carles Souto, Joan ;
Canals, Carme ;
Nomdedeu, Josep ;
Fontcuberta, Jordi .
HAEMATOLOGICA, 2007, 92 (02) :285-286
[7]   JAK2 V617F mutation in classic chronic myeloproliferative diseases:: a report on a series of 349 patients [J].
Vizmanos, JL ;
Ormazábal, C ;
Larráyoz, MJ ;
Cross, NCP ;
Calasanz, MJ .
LEUKEMIA, 2006, 20 (03) :534-535